Export this record

Export record to excel

File type to download

Beta version

Select record 1

ArticlesPeer ReviewedFull Text

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

Author / Creator:Pierga, Jean-Yves, Prof ; Petit, Thierry, Prof ; Delozier, Thierry, MD ; Ferrero, Jean-Marc, Prof ; Campone, Mario, MD ; Gligorov, Joseph, MD ; Lerebours, Florence, MD ; Roché, Henri, Prof ; Bachelot, Thomas, MD ; Charafe-Jauffret, Emmanuelle, Prof ; Pavlyuk, Maria, MD ; Kraemer, Sandrine, MSc ; Bidard, François-Clément, MD ; Viens, Patrice, Prof

Publisher:England: Elsevier Ltd

Journal title:The lancet oncology, 2012-04, Vol.13 (4), p.375-384

View online as a Library member

Export record to excel

Export this record

Export record to excel

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

Refine your search